A tailored approach to horizon scanning for cancer medicines

Authors: Soon, Jennifer A., To, Yat Hang, Alexander, Marliese, Trapani, Karen, Ascierto, Paolo A., Athan, Sophy, Brown, Michael P., Burge, Matthew, Haydon, Andrew, Hughes, Brett ^°, Itchins, Malinda, John, Thomas, Kao, Steven, Koopman, Miriam, Li, Bob T., Long, Georgina V., Loree, Jonathan M., Markman, Ben, Meniawy, Tarek M., Menzies, Alexander M., Nott, Louise, Pavlakis, Nick, Petrella, Teresa M., Popat, Sanjay, Tie, Jeanne, Xu, Wen, Yip, Desmond, Zalcberg, John, Solomon, Benjamin J., Gibbs, Peter, McArthur, Grant A., Franchini, Fanny, IJzerman, Maarten

Source: In Journal of Cancer Policy December 2023 38

Association between surveillance imaging and survival outcomes in small bowel neuroendocrine tumors

Authors: Watanabe, Akie, Mckendry, Geoffrey, Yip, Lily, Loree, Jonathan M., Stuart, Heather C.

Source: Journal of surgical oncology. 127(4):578-586

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173666242.0x000001&indx=1&recIds=ETOCvdc_100173666242.0x000001

The clinical impact of COVID-19 on patients with cancer in British Columbia: An observational study

Authors: Mathews, Angela S. ^{a, b}, Paul, Ashley ^{a, b}, Yu, Irene S. ^{a, b}, McGahan, Colleen ^a, Bhang, Eric ^{a, b}, Villa, Diego ^{a, b}, Gelmon, Karen ^{a, b}, Avina-Zubieta, Antonio ^{b, c}, Gerrie, Alina S. ^{a, b}, Lee, Ursula ^{a, b}, Chia, Stephen ^{a, b}, Woods, Ryan R. ^{a, d}, Loree, Jonathan M. ^{a, b, ∗}

Source: In Heliyon December 2022 8(12)

Real-world outcomes of lenvatinib therapy for advanced neuroendocrine neoplasms.

Authors: Vasconcelos, Joao Paulo Solar, Rodriguez, Jose Eduardo Nunez, Zaidi, Ali, Krishnan, Tharani, Jafari, Helia, Gill, Sharlene, Tan, Ann, Le, Dan, Chan, Theresa, Yu, Simon, McGhie, John Paul, Lim, Howard, Singh, Simron, Loree, Jonathan M.

Source: Endocrine-Related Cancer; Apr2025, Vol. 32 Issue 4, p86-92, 7p

Three Versus Six Months of Adjuvant Oxaliplatin-Containing Chemotherapy for Patients With Stage III Colorectal Cancer: A Contemporary Real-World Analysis.

Authors: Krishnan, Tharani, Leung, Emily, Solar Vasconcelos, Joao Paulo, Lim, Howard, Loree, Jonathan M., Davies, Janine, Gill, Karamjit, Gill, Sharlene

Source: JCO Oncology Practice; Mar2025, Vol. 21 Issue 3, p365-372, 8p

Subject Terms: THERAPEUTIC use of antineoplastic agents, THERAPEUTIC use of antimetabolites, COLORECTAL cancer, TREATMENT duration, RETROSPECTIVE studies, ADJUVANT chemotherapy, NEUROLOGICAL disorders, OXALIPLATIN, FOLINIC acid, MEDICAL records, ACQUISITION of data, TUMOR classification, FLUOROURACIL, DISEASE risk factors

Geographic Terms: CANADA

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-North America).

Authors: Lieu, Christopher Hanyoung, Yu, Guan, Kopetz, Scott, Puhalla, Shannon L., Lucas, Peter C., Sahin, Ibrahim Halil, Deming, Dustin A., Philip, Philip Agop, Hong, Theodore S., Rojas-Khalil, Yesenia, Loree, Jonathan M., Wolmark, Norman, Yothers, Greg, George, Thomas J., Dasari, Arvind

Source: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, pTPS310-TPS310, 307p

Identifying the optimal post-surgical timing of molecular residual disease (MRD) detection in colorectal cancer (CRC) using an ultra-sensitive assay: Interim results from the VICTORI study.

Authors: Solar Vasconcelos, Joao Paulo, Titmuss, Emma, Navarro, Fabio, Abbott, Charles, Chia, Brendan, Topham, James T, Ladua, Gale, Krishnan, Tharani, Hegebarth, Daniela, Lim, Howard J, Gill, Karamjit, Gill, Sharlene, Brown, Carl J., Ghuman, Amandeep, Meneghetti, Adam, Renouf, Daniel John, Schaeffer, David F., Chen, Richard, Boyle, Sean Michael, Loree, Jonathan M.

Source: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p275-275, 307p

Tumour-free ctDNA detection as a decision tool to support organ preservation in node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II NEO trial (CCTG CO.28).

Authors: Loree, Jonathan M., Titmuss, Emma, Brown, Carl J., Rich, Thereasa A., Tu, Dongsheng, Jonker, Derek J., O'Callaghan, Christopher J., Kennecke, Hagen Fritz

Source: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p20-20, 307p

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

Authors: Yu, Irene S., Al-Hashami, Zamzam, Chapani, Parv, Speers, Caroline, Davies, Janine M., Lim, Howard J., Renouf, Daniel J., Gill, Sharlene, Stuart, Heather C., Loree, Jonathan M.

Source: In Clinical Colorectal Cancer June 2022 21(2):107-113

Evaluation of Clinical and Pathological Factors to Predict High Risk of Recurrence in Patients With Stage II Colon Cancer

Authors: Cadham, Breanne, Parker, Brent, Yin, Yaling, Gill, Sharlene, Loree, Jonathan M., Cheung, Winson Y., Davies, Janine M.

Source: In Clinical Colorectal Cancer June 2022 21(2):e39-e48

The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space

Authors: Lau, Tammy T.Y., Sefid Dashti, Zahra J., Titmuss, Emma, Pender, Alexandra, Topham, James T., Bridgers, Joshua, Loree, Jonathan M., Feng, Xiaolan, Pleasance, Erin D., Renouf, Daniel J., Schrader, Kasmintan A., Sun, Sophie, Ho, Cheryl, Marra, Marco A., Laskin, Janessa, Karsan, Aly

Source: In The Journal of Molecular Diagnostics June 2022 24(6):609-618

A Real-World Observational Study of the Use and Associated Costs of Treating Neuroendocrine Tumors With Somatostatin Analogs in Canada

Authors: Cheung, Winson Y., LaForty, Callahan, Liovas, Anna, McKechnie, Heather, Loree, Jonathan M.

Source: Pancreas. 51(9):1146-1152

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100189932623.0x000001&indx=1&recIds=ETOCvdc_100189932623.0x000001

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results

Authors: Kennecke, Hagen F., O'Callaghan, Chris J., Loree, Jonathan M., Moloo, Hussein, Auer, Rebecca, Jonker, Derek J., Raval, Manoj, Musselman, Reilly, Ma, Grace, Caycedo-Marulanda, Antonio, Simianu, Vlad V., Patel, Sunil, Pitre, Lacey D., Helewa, Ramzi, Gordon, Vallerie L., Neumann, Katerina, Nimeiri, Halla, Sherry, Max, Tu, Dongsheng, Brown, Carl J.

Source: Journal of clinical oncology. 41(2):233-242

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100179829918.0x000001&indx=1&recIds=ETOCvdc_100179829918.0x000001

Well-Differentiated Grade 3 Neuroendocrine Tumors

Authors: Boutin, Mélina, Mathews, Angela, Badesha, Jasleen, Paul, Ashley, Safro, Maria, Gill, Sharlene, Stuart, Heather C., Schaeffer, David, Farnell, David, Loree, Jonathan M.

Source: Pancreas. 51(7):756-762

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178786746.0x000001&indx=1&recIds=ETOCvdc_100178786746.0x000001

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices

Authors: Malla, Midhun, Loree, Jonathan M, Kasi, Pashtoon Murtaza, Parikh, Aparna Raj

Source: Journal of clinical oncology. 40(24):2846-2857

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100169107795.0x000001&indx=1&recIds=ETOCvdc_100169107795.0x000001

Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms

Authors: Yang, Kevin C., Kalloger, Steve E., Aird, John J., Lee, Michael K.C., Rushton, Christopher, Mungall, Karen L., Mungall, Andrew J., Gao, Dongxia, Chow, Christine, Xu, Jing, Karasinska, Joanna M., Colborne, Shane, Jones, Steven J.M., Schrader, Jörg, Morin, Ryan D., Loree, Jonathan M., Marra, Marco A., Renouf, Daniel J., Morin, Gregg B., Schaeffer, David F., Gorski, Sharon M.

Source: In Cell Reports 12 October 2021 37(2)

Tumour grade and primary site predict patterns of recurrence and survival in patients with resected gastroenteropancreatic neuroendocrine tumors

Authors: Watanabe, Akie, Yip, Lily, Hamilton, Trevor D., Loree, Jonathan M., Stuart, Heather C.

Source: In The American Journal of Surgery June 2021 221(6):1141-1149

Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies

Authors: Mendis, Shehara, Anand, Seerat, Karasinska, Joanna M., Dasari, Arvind, Unger, Joseph M., Gothwal, Anirudh, Ellis, Lee M., Varadhachary, Gauri, Kopetz, Scott, Overman, Michael J., Raghav, Kanwal, Loree, Jonathan M.

Source: Oncologist. 26(2):107-114

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121027743.0x000001&indx=1&recIds=ETOCvdc_100121027743.0x000001

FOLFOXIRI plus Bevacizumab Versus FOLFOX plus Panitumumab for Metastatic Left‐Sided RAS/BRAF Wild‐Type Colorectal Cancer: Which 'Side' Are You On?

Authors: Yu, Irene S., Loree, Jonathan M.

Source: Oncologist. 26(4):277-280

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120200030.0x000001&indx=1&recIds=ETOCvdc_100120200030.0x000001

Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient.

Authors: Wu, Florence T.H., Topham, James T., O'Callaghan, Chris J., Feilotter, Harriet, Kennecke, Hagen F., Drusbosky, Leylah, Renouf, Daniel J., Jonker, Derek J., Tu, Dongsheng, Chen, Eric X., Loree, Jonathan M.

Source: JCO Precision Oncology; 12/1/2024, Vol. 8, p1-11, 11p

Subject Terms: CIRCULATING tumor DNA, RECEPTOR antibodies, OVERALL survival, COLORECTAL cancer, DISEASE progression